Senior insider sale
SVP, GC & Corporate Secretary at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.60M
39.58K shares
What this filing means
REED ELIZABETH E plans to sell 39.58K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.60M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2026ACC: 0001950047-26-009520
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
39.58K
Shares to sell
$2.60M
Approx. market value
39.58K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
9/15/2026
37.50KPerformance Stock Units
N/A
5/4/2026
2.08KTotal acquired39.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Exercise of Stock Options Cash | 37.50K | — |
5/4/2026 | Performance Stock Units N/A | 2.08K | — |
| Total | 39.58K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
39.58K
Market value
$2.60M
9/15/2026
Total
Units
39.58K
Value
$2.60M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/15/2026 | 39.58K | $2.60M | NASDAQ | Planned |
| Total | 39.58K | $2.60M | ||